That means a supplement patch can be sold without proving it works the company only needs to ensure the product is safe and not adulterated
At Skin Renewal, our doctor-led approach ensures every treatment is guided by medical expertise, safety and long-term skin health
Additionally, addressing emotional eating and building a supportive network are essential steps in your journey
Jonathan Zontag , lead study author and a researcher at Hebrew University
Patients experiencing hair thinning should be encouraged to discuss their concerns with their GP or prescribing clinician rather than discontinuing treatment abruptly, as the underlying condition being treated (diabetes or obesity) requires ongoing management
Key Takeaways Retatrutide targets three hormones (GLP-1, GIP, glucagon), tirzepatide targets two (GLP-1, GIP), and semaglutide targets one (GLP-1) At 68 weeks, retatrutide achieved 28.7% average weight loss, tirzepatide approximately 22%, and semaglutide around 17% on the highest doses Side effects are similar across all three medications, mainly digestive issues like nausea and diarrhoea Retatrutide is not yet approved and won't be available until mid-2026 at the earliest Retatrutide is not yet approved and is not currently available in the UK Tirzepatide (Mounjaro) and semaglutide (Wegovy) are both available now in the UK through NHS or private providers By entering I agree to the Terms and Conditions
.webp)
